Delivery Order 75N91022D00006-75N91023F00002
Award Date
6/15/23
Potential Completion Date
6/14/25
Potential Value
$3.4M
Federal Agency
National Cancer Institute
Awardee
Westat, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,784,848.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract is for support services related to studies of infection, immunity, and cancer, and has a period of performance through July 5, 2024. Westat has extensive experience supporting federal agencies, including the NCI, across a range of public health, research,...
This is a $21,248,975.00 cost-plus-fixed-fee delivery order contract awarded to Westat, Inc., a professional services firm in Rockville, Maryland, by the National Cancer Institute (NCI). The contract provides clinical, genetic, and epidemiological support services under the Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract does not have a small business set-aside designation....
This is a $32,485,777.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm. The contract supports the Infections and Immunoepidemiology Branch (IIB) and Integrative Tumor Epidemiology Branch (ITEB) of the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with field and biospecimen support services. This work is being conducted under the DCEG Field and Biospecimen Support Services indefinite...
This is a federal contract award to Westat, Inc., a prominent professional services firm, by the Centers for Disease Control and Prevention (CDC) for the "NATIONAL PROGRAM OF CANCER REGISTRIES-DATA QUALITY EVALUATION" project. The $1,045,658.00 cost-plus-fixed-fee contract is a delivery order under the CDC's "Technical and Management Support for Health Promotion Activities" Indefinite Delivery Vehicle (IDV). The contract has no set-aside designation and will run through...
This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract is for a "QUALITY ASSURANCE UNIT FOR THE HPV TYPE 16 VACCINE TRIAL IN COSTA RICA" with a ceiling value of $50,390,368.00. The contract is a Cost Plus Fixed Fee arrangement with an ultimate completion date of October 31, 2011. Westat has extensive experience providing...
This is a federal contract award to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract was awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (HHS). The contract is valued at $3,650,434.16 and is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract is for professional services and program management/support, with an ultimate completion date of July 31, 2021. Westat has...
This is a firm-fixed price contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Westat, Inc., a for-profit professional services provider. The contract, which is not set aside, has a potential value of $1,463,053.00 and a completion date of September 15, 2019. The contract supports the National Cancer Institute's cancer surveillance activities through the provision of professional support services in three areas: quality...
This is a $15,339,013.00 cost-plus-fixed-fee delivery order awarded to Westat, Inc. by the National Cancer Institute (NCI). The task order provides technical support services to the NCI's Division of Cancer Epidemiology and Genetics (DCEG) Metabolic Epidemiology Branch in accordance with the statement of work. The award is part of the DCEG Field and Biospecimen Support Services IDIQ contract vehicle. No set-aside was used for this award. Westat is a prominent professional services firm that...
This is a $25,000 firm-fixed-price delivery order awarded to Westat, Inc. by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. The order is for other functions/task order work under Westat's existing contract to support understanding cancer patient experiences and care using the PROMIS (Patient-Reported Outcomes Measurement Information System) platform. There is no set-aside designation for this award. Westat is a prominent...
This is a $19,307,275.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm headquartered in Rockville, Maryland. The contract is for occupational and environmental epidemiology support services to the NCI's Occupational and Environmental Epidemiology Branch (OEEB), with a period of performance through September 2030. The contract is a task order issued under the NCI's Division of Cancer Epidemiology and...